Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.

@article{Caldern2012ComparabilityOS,
  title={Comparability of subcutaneous and sublingual immunotherapy outcomes in allergic rhinitis clinical trials.},
  author={Moises A. Calder{\'o}n and Andrea Eichel and Melina Makatsori and Oliver Pfaar},
  journal={Current opinion in allergy and clinical immunology},
  year={2012},
  volume={12 3},
  pages={249-56}
}
PURPOSE OF REVIEW To conduct a qualitative comparison between the primary and secondary outcomes used in clinical trials of subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) for allergic rhinitis. RECENT FINDINGS Studies of SCIT and SLIT for allergic rhinitis published up to January 2012 were included in this systematic review. Different ways of defining primary and secondary outcome parameters in studies investigating specific immunotherapy are described. Whereas older… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 3 times. VIEW TWEETS

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 17 extracted citations

SLIT: indications, follow-up, and management.

Journal of investigational allergology & clinical immunology • 2014
View 20 Excerpts
Highly Influenced

SPIREs: a new horizon for allergic disease treatment?

Expert review of clinical immunology • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…